Dr. Ligia Rodina is a physician and clinical researcher specializing in infectious diseases and endocrine-metabolic interactions, with a particular focus on post-COVID-19 sequelae. Her research interests include the metabolic and immunologic consequences of viral infections, endocrine dysfunction in systemic diseases, and clinical predictors of severe infectious outcomes. She has published studies on the relationship between admission hyperglycemia and COVID-19 severity, as well as on long-term thyroid and glucose metabolism alterations in post-COVID cohorts. Additionally, Dr. Rodina has contributed to research on COVID-19 infection in infants and newborns, addressing specific clinical and epidemiological aspects of this vulnerable population.